Thorney Technologies Limited (AU:TEK) has released an update.
Thorney Technologies Ltd (TEK), an ASX-listed tech-focused investment company, reported a pre-tax NTA increase of 4.5% for September 2024, driven by strong performances in key portfolio holdings like Clarity Pharmaceuticals, Calix, and Avita Medical. Despite a challenging market for technology IPOs, TEK is actively managing its portfolio, leveraging its on-market share buyback program to mitigate the discount between share price and NTA. The company’s investment strategy continues to target early-stage technology companies with disruptive potential across various sectors.
For further insights into AU:TEK stock, check out TipRanks’ Stock Analysis page.
